Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-27

Clinical Trial Update: Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA) [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating adalimumab for knee osteoarthritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: CARE ARTHRITIS LTD. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED